🇺🇸 Sulperazon in United States

413 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Platelet Count Decreased — 67 reports (16.22%)
  2. Pyrexia — 48 reports (11.62%)
  3. Anaphylactic Shock — 44 reports (10.65%)
  4. Hepatic Function Abnormal — 44 reports (10.65%)
  5. Pneumonia — 40 reports (9.69%)
  6. White Blood Cell Count Decreased — 37 reports (8.96%)
  7. Alanine Aminotransferase Increased — 35 reports (8.47%)
  8. Aspartate Aminotransferase Increased — 34 reports (8.23%)
  9. Condition Aggravated — 33 reports (7.99%)
  10. Off Label Use — 31 reports (7.51%)

Source database →

Sulperazon in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Sulperazon approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Sulperazon in United States?

Tongji Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.